Mangat: Generative AI will rewrite software across every industry vertical
Ranvir Mangat · Precision Dosing & AI in Healthcare: InsightRx’s Journey to Transform Medication Personalization · Aug 22, 2025 · at 31:14
InsightRx co-founder and COO Ranvir Mangat discusses how generative AI is shifting software architecture and user experience paradigms across enterprise software markets.
0:00 / 0:16exact quote · 16.9s
720p mp4 · rendered on demand · StarZero watermark
“I think you're going to see Pretty much every software, every industry vertical be kind of rewritten around and a gen AI native stack or user interface or technology stack.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Ranvir Mangat
Mangat: Hospital Pharmacy ROI Is Challenging Because Savings Accrue to Other Budgets
“When you're in healthcare, it's in our case, we're selling to the pharmacy and the pharmacy is more of a cost center. So trying to translate sometimes to the fact that maybe you're saving on adverse events that goes to someone else's budget or maybe the CMO. S…”
Mangat: Selling to Health Insurers Requires Massive Scale and Major Cost Problems
“If you're dealing with insurance companies, you know, they are, in our experience, they are looking at their top 10 problems, or even their top five problems, and the amount of scale you need to have to be able to have a value prop for an insurance company, it…”
Mangat: AI workflows will require humans in loop until AGI
“I still think though, that you're always going to have a, Human in the loop. Maybe for another, I, you know, I'm not going to project how many five years, how many years, five years or 10 years, but, you know, until you get that AGI that happens you know, ther…”
Mangat: Healthcare dosing protocols are typically designed for one-size-fits-all patients
“When you look at healthcare and you see the dosing protocols that are out there, they're typically designed for, you know, a one size fits all patient.”